Site Management

a.) Unveils Draft Guidance for Medical Device Interoperability

The U.S. Food and Drug Administration on Tuesday unveiled draft guidance it hopes the medical device industry will follow for including interoperability in the design and development of such tools.

b.) ABIVAX announces positive top-line clinical Phase IIa data for novel HIV drug-candidate ABX464

BIVAX, an emerging leader in developing and commercializing novel antiviral therapies for diseases like HIV/AIDS and chronic Hepatitis B (CHB), today announced positive top-line efficacy and safety results from the Company's Phase IIa clinical study (ABX464-003) in patients with HIV infection.

c.) Industry is responding well to Innovate Research

Recent press release done by team , reveals that Innovate Research has become one of the most emerging names in domestic circuit. They have been delivering projects on time and within budget of the Pharma companies

d.) Profectus BioSciences Initiates Ebola Vaccine Phase 1 Clinical Trial

Profectus BioSciences, Inc., a clinical-stage vaccine company developing novel vaccines for the prevention and treatment of infectious diseases and the treatment of cancer, announced today the initiation of a Phase 1 clinical study of Profectus' VesiculoVax™-vectored Ebola virus vaccine. The vaccine is a version of the company's patented VSV vector that has been engineered for safe use in humans and to express the surface protein of Ebola virus. In preclinical studies, a single dose of this vaccine completely protected monkeys against the strain of Ebola virus responsible for the recent outbreak in West Africa

Innovate Research CRO



Within India

0 120 4797021

Outside India

+91 120 4797021

G-07, Newbridge Business Centre, 1st Floor,
Inox Tower-B, Plot No. 17, Sector-16A, Film city,
Noida, India 201301

Send Online Enquiry